12780 EL CAMINO REAL, SAN DIEGO, CA
Completes Acquisition of Soleno Therapeutics
Reports First-Quarter 2026 Financial Results
Annual Report to Security Holders
Material Contracts
Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
Changes in Board, Management or Compensation
Reports Third Quarter 2025 Financial Results
Financial Results, Press Release
Q1
FY 2024
Q3
Q2
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Third Party
S-8 POS